Inebilizumab for Neuromyelitis Optica Spectrum Disorder
Abstract
Neuromyelitis optica spectrum disorder (NMOSD) has one recently approved therapy (NEJM JW Neurol Aug 2019 and N Engl J Med 2019; 381:614) and...
Paper Details
Title
Inebilizumab for Neuromyelitis Optica Spectrum Disorder
Published Date
Sep 30, 2019
Journal
Volume
2019
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History